nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—Irinotecan—pancreatic cancer	0.207	0.376	CbGbCtD
Perindopril—ABCB1—Tamoxifen—pancreatic cancer	0.0684	0.124	CbGbCtD
Perindopril—ABCB1—Gemcitabine—pancreatic cancer	0.059	0.107	CbGbCtD
Perindopril—ABCB1—Erlotinib—pancreatic cancer	0.0582	0.106	CbGbCtD
Perindopril—ABCB1—Irinotecan—pancreatic cancer	0.0525	0.0954	CbGbCtD
Perindopril—ABCB1—Docetaxel—pancreatic cancer	0.0385	0.0699	CbGbCtD
Perindopril—ABCB1—Sunitinib—pancreatic cancer	0.0383	0.0696	CbGbCtD
Perindopril—ABCB1—Doxorubicin—pancreatic cancer	0.0287	0.0521	CbGbCtD
Perindopril—Conjunctivitis—Epirubicin—pancreatic cancer	0.000246	0.000549	CcSEcCtD
Perindopril—Urinary tract infection—Epirubicin—pancreatic cancer	0.000246	0.000549	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—pancreatic cancer	0.000246	0.000548	CcSEcCtD
Perindopril—Dry mouth—Docetaxel—pancreatic cancer	0.000245	0.000544	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000245	0.000544	CcSEcCtD
Perindopril—Sweating—Epirubicin—pancreatic cancer	0.000243	0.000541	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—pancreatic cancer	0.000243	0.000541	CcSEcCtD
Perindopril—Asthenia—Gemcitabine—pancreatic cancer	0.000242	0.00054	CcSEcCtD
Perindopril—Haematuria—Epirubicin—pancreatic cancer	0.000242	0.000538	CcSEcCtD
Perindopril—Confusional state—Docetaxel—pancreatic cancer	0.000242	0.000538	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00024	0.000535	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00024	0.000534	CcSEcCtD
Perindopril—Oedema—Docetaxel—pancreatic cancer	0.00024	0.000534	CcSEcCtD
Perindopril—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00024	0.000534	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—pancreatic cancer	0.000239	0.000532	CcSEcCtD
Perindopril—Pruritus—Gemcitabine—pancreatic cancer	0.000239	0.000532	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—pancreatic cancer	0.000238	0.00053	CcSEcCtD
Perindopril—Diarrhoea—Irinotecan—pancreatic cancer	0.000237	0.000528	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—pancreatic cancer	0.000237	0.000527	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—pancreatic cancer	0.000236	0.000525	CcSEcCtD
Perindopril—Shock—Docetaxel—pancreatic cancer	0.000236	0.000525	CcSEcCtD
Perindopril—Nervous system disorder—Docetaxel—pancreatic cancer	0.000235	0.000523	CcSEcCtD
Perindopril—Pruritus—Fluorouracil—pancreatic cancer	0.000235	0.000523	CcSEcCtD
Perindopril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000235	0.000523	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—pancreatic cancer	0.000235	0.000522	CcSEcCtD
Perindopril—Tachycardia—Docetaxel—pancreatic cancer	0.000234	0.000521	CcSEcCtD
Perindopril—Skin disorder—Docetaxel—pancreatic cancer	0.000233	0.000518	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000233	0.000518	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—pancreatic cancer	0.000232	0.000516	CcSEcCtD
Perindopril—Diarrhoea—Gemcitabine—pancreatic cancer	0.000231	0.000515	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—pancreatic cancer	0.000231	0.000513	CcSEcCtD
Perindopril—Dizziness—Irinotecan—pancreatic cancer	0.000229	0.000511	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—pancreatic cancer	0.000229	0.000509	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—pancreatic cancer	0.000229	0.000509	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—pancreatic cancer	0.000229	0.000509	CcSEcCtD
Perindopril—Anorexia—Docetaxel—pancreatic cancer	0.000229	0.000509	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—pancreatic cancer	0.000228	0.000508	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000228	0.000508	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000228	0.000508	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—pancreatic cancer	0.000228	0.000507	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—pancreatic cancer	0.000228	0.000507	CcSEcCtD
Perindopril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000227	0.000506	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—pancreatic cancer	0.000226	0.000503	CcSEcCtD
Perindopril—Sweating—Doxorubicin—pancreatic cancer	0.000225	0.000501	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000225	0.0005	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—pancreatic cancer	0.000224	0.000499	CcSEcCtD
Perindopril—Hypotension—Docetaxel—pancreatic cancer	0.000224	0.000499	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—pancreatic cancer	0.000224	0.000498	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—pancreatic cancer	0.000223	0.000497	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000222	0.000494	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—pancreatic cancer	0.000221	0.000493	CcSEcCtD
Perindopril—Vomiting—Irinotecan—pancreatic cancer	0.000221	0.000491	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—pancreatic cancer	0.00022	0.00049	CcSEcCtD
Perindopril—Dizziness—Fluorouracil—pancreatic cancer	0.00022	0.000489	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—pancreatic cancer	0.000219	0.000488	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000219	0.000487	CcSEcCtD
Perindopril—Rash—Irinotecan—pancreatic cancer	0.000219	0.000487	CcSEcCtD
Perindopril—Dermatitis—Irinotecan—pancreatic cancer	0.000219	0.000486	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000218	0.000486	CcSEcCtD
Perindopril—Headache—Irinotecan—pancreatic cancer	0.000217	0.000484	CcSEcCtD
Perindopril—Insomnia—Docetaxel—pancreatic cancer	0.000217	0.000483	CcSEcCtD
Perindopril—Paraesthesia—Docetaxel—pancreatic cancer	0.000215	0.000479	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000215	0.000479	CcSEcCtD
Perindopril—Vomiting—Gemcitabine—pancreatic cancer	0.000215	0.000478	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—pancreatic cancer	0.000214	0.000477	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—pancreatic cancer	0.000214	0.000476	CcSEcCtD
Perindopril—Somnolence—Docetaxel—pancreatic cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Rash—Gemcitabine—pancreatic cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Dermatitis—Gemcitabine—pancreatic cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—pancreatic cancer	0.000213	0.000474	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—pancreatic cancer	0.000212	0.000472	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—pancreatic cancer	0.000212	0.000471	CcSEcCtD
Perindopril—Headache—Gemcitabine—pancreatic cancer	0.000212	0.000471	CcSEcCtD
Perindopril—Flushing—Epirubicin—pancreatic cancer	0.000211	0.00047	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—pancreatic cancer	0.000211	0.00047	CcSEcCtD
Perindopril—Vomiting—Fluorouracil—pancreatic cancer	0.000211	0.00047	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—pancreatic cancer	0.000211	0.00047	CcSEcCtD
Perindopril—Dyspepsia—Docetaxel—pancreatic cancer	0.000211	0.00047	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—pancreatic cancer	0.000211	0.000469	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—pancreatic cancer	0.000211	0.000469	CcSEcCtD
Perindopril—Rash—Fluorouracil—pancreatic cancer	0.000209	0.000466	CcSEcCtD
Perindopril—Dermatitis—Fluorouracil—pancreatic cancer	0.000209	0.000466	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—pancreatic cancer	0.000209	0.000465	CcSEcCtD
Perindopril—Decreased appetite—Docetaxel—pancreatic cancer	0.000208	0.000464	CcSEcCtD
Perindopril—Headache—Fluorouracil—pancreatic cancer	0.000208	0.000463	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000208	0.000463	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000208	0.000462	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000207	0.000461	CcSEcCtD
Perindopril—Fatigue—Docetaxel—pancreatic cancer	0.000207	0.00046	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—pancreatic cancer	0.000207	0.00046	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—pancreatic cancer	0.000206	0.00046	CcSEcCtD
Perindopril—Nausea—Irinotecan—pancreatic cancer	0.000206	0.000459	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000205	0.000457	CcSEcCtD
Perindopril—Pain—Docetaxel—pancreatic cancer	0.000205	0.000456	CcSEcCtD
Perindopril—Constipation—Docetaxel—pancreatic cancer	0.000205	0.000456	CcSEcCtD
Perindopril—Chills—Epirubicin—pancreatic cancer	0.000204	0.000455	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—pancreatic cancer	0.000203	0.000453	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—pancreatic cancer	0.000203	0.000452	CcSEcCtD
Perindopril—Alopecia—Epirubicin—pancreatic cancer	0.000201	0.000448	CcSEcCtD
Perindopril—Nausea—Gemcitabine—pancreatic cancer	0.000201	0.000447	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—pancreatic cancer	0.000199	0.000444	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000199	0.000443	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—pancreatic cancer	0.000198	0.000441	CcSEcCtD
Perindopril—Erythema—Epirubicin—pancreatic cancer	0.000198	0.000441	CcSEcCtD
Perindopril—Feeling abnormal—Docetaxel—pancreatic cancer	0.000198	0.00044	CcSEcCtD
Perindopril—Nausea—Fluorouracil—pancreatic cancer	0.000197	0.000439	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—pancreatic cancer	0.000197	0.000438	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—pancreatic cancer	0.000196	0.000437	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000196	0.000436	CcSEcCtD
Perindopril—Flushing—Doxorubicin—pancreatic cancer	0.000195	0.000435	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000195	0.000435	CcSEcCtD
Perindopril—Flatulence—Epirubicin—pancreatic cancer	0.000195	0.000435	CcSEcCtD
Perindopril—Tension—Epirubicin—pancreatic cancer	0.000194	0.000433	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—pancreatic cancer	0.000194	0.000432	CcSEcCtD
Perindopril—Nervousness—Epirubicin—pancreatic cancer	0.000192	0.000428	CcSEcCtD
Perindopril—Back pain—Epirubicin—pancreatic cancer	0.000192	0.000427	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—pancreatic cancer	0.000191	0.000425	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—pancreatic cancer	0.000191	0.000424	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00019	0.000423	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—pancreatic cancer	0.00019	0.000422	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—pancreatic cancer	0.00019	0.000422	CcSEcCtD
Perindopril—Chills—Doxorubicin—pancreatic cancer	0.000189	0.000421	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—pancreatic cancer	0.000188	0.000419	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—pancreatic cancer	0.000186	0.000414	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—pancreatic cancer	0.000185	0.000411	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000184	0.000409	CcSEcCtD
Perindopril—Erythema—Doxorubicin—pancreatic cancer	0.000183	0.000408	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—pancreatic cancer	0.000183	0.000408	CcSEcCtD
Perindopril—Anaemia—Epirubicin—pancreatic cancer	0.000183	0.000408	CcSEcCtD
Perindopril—Agitation—Epirubicin—pancreatic cancer	0.000182	0.000405	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—pancreatic cancer	0.000181	0.000402	CcSEcCtD
Perindopril—Tension—Doxorubicin—pancreatic cancer	0.00018	0.0004	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—pancreatic cancer	0.00018	0.0004	CcSEcCtD
Perindopril—Malaise—Epirubicin—pancreatic cancer	0.000179	0.000398	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—pancreatic cancer	0.000178	0.000396	CcSEcCtD
Perindopril—Vertigo—Epirubicin—pancreatic cancer	0.000178	0.000396	CcSEcCtD
Perindopril—Syncope—Epirubicin—pancreatic cancer	0.000178	0.000396	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—pancreatic cancer	0.000177	0.000395	CcSEcCtD
Perindopril—Back pain—Doxorubicin—pancreatic cancer	0.000177	0.000395	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—pancreatic cancer	0.000176	0.000392	CcSEcCtD
Perindopril—Palpitations—Epirubicin—pancreatic cancer	0.000175	0.00039	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000174	0.000388	CcSEcCtD
Perindopril—Cough—Epirubicin—pancreatic cancer	0.000173	0.000385	CcSEcCtD
Perindopril—Asthenia—Docetaxel—pancreatic cancer	0.000172	0.000383	CcSEcCtD
Perindopril—Hypertension—Epirubicin—pancreatic cancer	0.000171	0.000381	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00017	0.000379	CcSEcCtD
Perindopril—Pruritus—Docetaxel—pancreatic cancer	0.00017	0.000378	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—pancreatic cancer	0.000169	0.000377	CcSEcCtD
Perindopril—Chest pain—Epirubicin—pancreatic cancer	0.000169	0.000376	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—pancreatic cancer	0.000169	0.000376	CcSEcCtD
Perindopril—Myalgia—Epirubicin—pancreatic cancer	0.000169	0.000376	CcSEcCtD
Perindopril—Agitation—Doxorubicin—pancreatic cancer	0.000169	0.000375	CcSEcCtD
Perindopril—Anxiety—Epirubicin—pancreatic cancer	0.000168	0.000374	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000168	0.000373	CcSEcCtD
Perindopril—Discomfort—Epirubicin—pancreatic cancer	0.000167	0.000371	CcSEcCtD
Perindopril—Malaise—Doxorubicin—pancreatic cancer	0.000165	0.000368	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—pancreatic cancer	0.000165	0.000367	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—pancreatic cancer	0.000165	0.000367	CcSEcCtD
Perindopril—Syncope—Doxorubicin—pancreatic cancer	0.000164	0.000366	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—pancreatic cancer	0.000164	0.000365	CcSEcCtD
Perindopril—Diarrhoea—Docetaxel—pancreatic cancer	0.000164	0.000365	CcSEcCtD
Perindopril—Confusional state—Epirubicin—pancreatic cancer	0.000163	0.000363	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—pancreatic cancer	0.000162	0.000361	CcSEcCtD
Perindopril—Oedema—Epirubicin—pancreatic cancer	0.000162	0.00036	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000162	0.00036	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000161	0.000359	CcSEcCtD
Perindopril—Cough—Doxorubicin—pancreatic cancer	0.00016	0.000356	CcSEcCtD
Perindopril—Shock—Epirubicin—pancreatic cancer	0.000159	0.000354	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—pancreatic cancer	0.000159	0.000353	CcSEcCtD
Perindopril—Dizziness—Docetaxel—pancreatic cancer	0.000159	0.000353	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000158	0.000352	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—pancreatic cancer	0.000158	0.000352	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—pancreatic cancer	0.000158	0.000351	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—pancreatic cancer	0.000157	0.00035	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000156	0.000348	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—pancreatic cancer	0.000156	0.000347	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—pancreatic cancer	0.000156	0.000347	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—pancreatic cancer	0.000156	0.000347	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—pancreatic cancer	0.000156	0.000346	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000155	0.000345	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—pancreatic cancer	0.000154	0.000343	CcSEcCtD
Perindopril—Anorexia—Epirubicin—pancreatic cancer	0.000154	0.000343	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—pancreatic cancer	0.000153	0.00034	CcSEcCtD
Perindopril—Vomiting—Docetaxel—pancreatic cancer	0.000152	0.000339	CcSEcCtD
Perindopril—Rash—Docetaxel—pancreatic cancer	0.000151	0.000337	CcSEcCtD
Perindopril—Hypotension—Epirubicin—pancreatic cancer	0.000151	0.000336	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—pancreatic cancer	0.000151	0.000336	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—pancreatic cancer	0.000151	0.000336	CcSEcCtD
Perindopril—Headache—Docetaxel—pancreatic cancer	0.00015	0.000334	CcSEcCtD
Perindopril—Oedema—Doxorubicin—pancreatic cancer	0.00015	0.000333	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00015	0.000333	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000147	0.000328	CcSEcCtD
Perindopril—Shock—Doxorubicin—pancreatic cancer	0.000147	0.000328	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000147	0.000327	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000147	0.000326	CcSEcCtD
Perindopril—Insomnia—Epirubicin—pancreatic cancer	0.000146	0.000326	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—pancreatic cancer	0.000146	0.000325	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—pancreatic cancer	0.000145	0.000324	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—pancreatic cancer	0.000145	0.000323	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000145	0.000322	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—pancreatic cancer	0.000144	0.000321	CcSEcCtD
Perindopril—Somnolence—Epirubicin—pancreatic cancer	0.000144	0.00032	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—pancreatic cancer	0.000143	0.000318	CcSEcCtD
Perindopril—Nausea—Docetaxel—pancreatic cancer	0.000142	0.000317	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—pancreatic cancer	0.000142	0.000317	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—pancreatic cancer	0.000141	0.000313	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—pancreatic cancer	0.00014	0.000311	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00014	0.000311	CcSEcCtD
Perindopril—Fatigue—Epirubicin—pancreatic cancer	0.000139	0.00031	CcSEcCtD
Perindopril—Constipation—Epirubicin—pancreatic cancer	0.000138	0.000308	CcSEcCtD
Perindopril—Pain—Epirubicin—pancreatic cancer	0.000138	0.000308	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000136	0.000303	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—pancreatic cancer	0.000135	0.000301	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—pancreatic cancer	0.000134	0.000299	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—pancreatic cancer	0.000133	0.000297	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—pancreatic cancer	0.000133	0.000297	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—pancreatic cancer	0.000133	0.000296	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000132	0.000294	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000132	0.000293	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—pancreatic cancer	0.00013	0.00029	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000129	0.000288	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—pancreatic cancer	0.000129	0.000287	CcSEcCtD
Perindopril—Urticaria—Epirubicin—pancreatic cancer	0.000128	0.000286	CcSEcCtD
Perindopril—Constipation—Doxorubicin—pancreatic cancer	0.000128	0.000285	CcSEcCtD
Perindopril—Pain—Doxorubicin—pancreatic cancer	0.000128	0.000285	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—pancreatic cancer	0.000128	0.000285	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—pancreatic cancer	0.000128	0.000285	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000123	0.000274	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000122	0.000272	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—pancreatic cancer	0.000119	0.000265	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—pancreatic cancer	0.000118	0.000263	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000118	0.000263	CcSEcCtD
Perindopril—Asthenia—Epirubicin—pancreatic cancer	0.000116	0.000258	CcSEcCtD
Perindopril—Pruritus—Epirubicin—pancreatic cancer	0.000114	0.000255	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—pancreatic cancer	0.000111	0.000246	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—pancreatic cancer	0.000107	0.000239	CcSEcCtD
Perindopril—Dizziness—Epirubicin—pancreatic cancer	0.000107	0.000238	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—pancreatic cancer	0.000106	0.000236	CcSEcCtD
Perindopril—Vomiting—Epirubicin—pancreatic cancer	0.000103	0.000229	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—pancreatic cancer	0.000102	0.000228	CcSEcCtD
Perindopril—Rash—Epirubicin—pancreatic cancer	0.000102	0.000227	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—pancreatic cancer	0.000102	0.000227	CcSEcCtD
Perindopril—Headache—Epirubicin—pancreatic cancer	0.000101	0.000226	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—pancreatic cancer	9.9e-05	0.00022	CcSEcCtD
Perindopril—Nausea—Epirubicin—pancreatic cancer	9.61e-05	0.000214	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—pancreatic cancer	9.52e-05	0.000212	CcSEcCtD
Perindopril—Rash—Doxorubicin—pancreatic cancer	9.44e-05	0.00021	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—pancreatic cancer	9.43e-05	0.00021	CcSEcCtD
Perindopril—Headache—Doxorubicin—pancreatic cancer	9.38e-05	0.000209	CcSEcCtD
Perindopril—Nausea—Doxorubicin—pancreatic cancer	8.89e-05	0.000198	CcSEcCtD
